FDA’s New COVID Shot Rules—What’s Up?

The FDA just gave Novavax’s new COVID shot the green light, but only for seniors and high-risk folks—not everyone. Unlike Pfizer and Moderna, which are approved for anyone 12+, Novavax’s shot is limited to those 65+ or people 12-64 with health risks. Plus, the FDA wants more safety data, especially for heart issues. And heads up: the whole vaccine approval process might be changing soon, with talks of new rules and even dropping COVID shots from the kids’ vaccine list. Stay tuned! #COVID19 #Novavax #FDA #VaccineUpdate #HealthNews #Health